J. Keruly

发表

Improvement in the health of HIV-infected persons in care: reducing disparities.

Richard D Moore, J. Bartlett, J. Keruly, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Correlates of Patterns of Health Values of African Americans Living With HIV/AIDS: Implications for Advance Care Planning and HIV Palliative Care.

C. Rushton, L. Wissow, L. Bone, 2018, Journal of Pain and Symptom Management.

Impact of a Youth-Focused Care Model on Retention and Virologic Suppression Among Young Adults With HIV Cared for in an Adult HIV Clinic

J. Keruly, A. Agwu, D. Griffith, 2019, Journal of acquired immune deficiency syndromes.

Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?

Jeanne Keruly, Mary Catherine Beach, Richard D Moore, 2006, Journal of general internal medicine.

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

R. Chaisson, D. Richman, J. Keruly, 1992, The American review of respiratory disease.

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.

Richard D Moore, J. Keruly, Richard D. Moore, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of supervised, intermittent therapy for tuberculosis in HIV‐infected patients

R. Chaisson, C. Chaulk, J. Keruly, 1994, AIDS.

Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.

Richard D Moore, J. Gallant, J. Keruly, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.

Richard D Moore, B. Lau, D. Fine, 2008, The Journal of infectious diseases.

HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms

Richard D Moore, E. Fishman, S. Lai, 2016, Journal of the American Heart Association.

An Improvement in Virologic Response to Highly Active Antiretroviral Therapy in Clinical Practice From 1996 Through 2002

Richard D Moore, K. Gebo, G. Lucas, 2005, Journal of acquired immune deficiency syndromes.

Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer.

Richard D Moore, M. Brock, T. Brown, 2012, The Annals of thoracic surgery.

Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients.

R. Chaisson, J. Gallant, J. Keruly, 1996, The Journal of infectious diseases.

HIV-Infection as a Prognostic Factor in Surgical Patients with Non-Small Cell Lung Cancer

T. Brown, Beverly Lee, James J. Shin, 2012 .

Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals

Richard D Moore, L. Wilson, K. Gebo, 2008, AIDS.

Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.

Richard D Moore, R. Chaisson, Michael E Griswold, 2006, American journal of epidemiology.

Chronic Pain, Patient-Physician Engagement, and Family Communication Associated With Drug-Using HIV Patients' Discussing Advanced Care Planning With Their Physicians.

A. Knowlton, J. Keruly, M. Mitchell, 2017, Journal of pain and symptom management.

Risk Factors for Kaposi's Sarcoma in Patients With Advanced Human Immunodeficiency Virus Disease Treated With Zidovudine

Richard D Moore, R. Chaisson, D. Richman, 1994 .

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

R. Chaisson, D. Richman, J. Gallant, 1992, The Journal of infectious diseases.

Lack of sex difference in CD4 to HIV-1 RNA viral load ratio

Richard D Moore, R. Chaisson, L. Cheever, 1999, The Lancet.

Assessing effects of behavioral intervention on treatment outcomes among patients initiating HIV care: Rationale and design of iENGAGE intervention trial.

Riddhi A Modi, A. Westfall, J. Willig, 2018, Contemporary clinical trials.

Detection of Legionella pneumophila DNA in urine and serum samples from patients with pneumonia

J. Keruly, M. Romagnoli, W. Merz, 2000 .

Early mortality and cause of deaths in patients using HAART in Brazil and the United States

Richard D Moore, V. Veloso, B. Grinsztejn, 2009, AIDS.

Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March–December 2020

Richard D Moore, M. Saag, A. Webel, 2022, Journal of acquired immune deficiency syndromes.

Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States

M. Saag, B. Whitney, J. Eron, 2022, AIDS.

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status.

Richard D Moore, K. Gebo, G. Lucas, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to Gupta

Richard D Moore, J. Gallant, J. Keruly, 2005 .

Neutropenia and bacterial infection in acquired immunodeficiency syndrome.

R. Chaisson, J. Keruly, R. Moore, 1995, Archives of internal medicine.

The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study

Y. Manabe, J. Keruly, David L. Thomas, 2020, medRxiv.

Increasing incidence of avascular necrosis of the hip in HIV-infected patients.

R. Chaisson, J. Keruly, R. Moore, 2001, Journal of acquired immune deficiency syndromes.

Lack of Association between Acyclovir Use and Survival in Patients with Advanced Human Immunodeficiency Virus Disease Treated with Zidovudine

Richard D Moore, R. Chaisson, D. Richman, 1995 .

Post‐sequelae symptoms and comorbidities after COVID‐19

P. Duggal, C. Vergara, J. Keruly, 2022, Journal of medical virology.

Clinic-Level Factors Associated With Retention in Care Among People Living With Human Immunodeficiency Virus in a Multisite US Cohort, 2010–2016

M. Mugavero, P. Rebeiro, E. Geng, 2020 .

Gaps Up To 9 Months Between HIV Primary Care Visits Do Not Worsen Viral Load

G. Marks, L. Gardner, U. Patel, 2018, AIDS patient care and STDs.

Exploring definitions of retention in care for people living with HIV in the United States in the modern treatment era

Catherine R. Lesko, M. Mugavero, P. Rebeiro, 2022, AIDS.

Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort

Richard D Moore, J. Fleishman, J. Aberg, 2017, PloS one.

Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990–2003

Richard D Moore, P. Barry, K. Gebo, 2006, AIDS.

Adverse events from drug therapy for human immunodeficiency virus disease.

R. Chaisson, J. Keruly, R. Moore, 1996, The American journal of medicine.

Long-term Safety and Efficacy of Zidovudine in Patients With Advanced Human Immunodeficiency Virus Disease

Richard D Moore, R. Chaisson, D. Richman, 1991 .

Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients.

R. Chaisson, J. Gallant, J. Keruly, 1999, AIDS (London).

Pneumocystis Prophylaxis and Survival in Patients With Advanced Human Immunodeficiency Virus Infection Treated With Zidovudine

Richard D Moore, R. Chaisson, D. Richman, 1992 .

Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology.

J. Gallant, J. Keruly, R. Moore, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

T-cell enumeration from dried blood spots by quantifying rearranged T-cell receptor-beta genes.

T. Quinn, R. Gray, D. Serwadda, 2010, Journal of immunological methods.

Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.

R. Chaisson, D. Richman, J. Keruly, 1992, Archives of internal medicine.

Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical Data

Richard D Moore, J. Fleishman, J. Aberg, 2017, Journal of acquired immune deficiency syndromes.

Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, Brazil.

Richard D Moore, V. Veloso, B. Grinsztejn, 2010, AIDS research and human retroviruses.

Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection.

R. Chaisson, J. Keruly, R. Moore, 2000, American journal of respiratory and critical care medicine.

Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea

J. McArthur, J. Keruly, R.D. Moore, 2000, AIDS.

Anemia and survival in HIV infection.

R. Chaisson, J. Keruly, R. Moore, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Impact of opportunistic disease on survival in patients with HIV infection

R. Chaisson, J. Gallant, J. Keruly, 1998, AIDS.

Incidence and Natural History of Cytomegalovirus Disease in Patients With Advanced Human Immune Deficiency Virus Disease Treated With Zidovudine: The Zidovudine Epidemiology Study Group

Richard D Moore, D. Richman, J. Gallant, 1993 .

Race, sex, drug use, and progression of human immunodeficiency virus disease.

R. Chaisson, J. Keruly, R. Moore, 1995, The New England journal of medicine.

Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs

R. Chaisson, J. Keruly, R. Moore, 2001, AIDS.

Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy.

R. Chaisson, J. Keruly, R. Moore, 2000, JAMA.

Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy

J. Eron, J. Keruly, S. Napravnik, 2007, HIV medicine.

Delayed Diagnosis and Elevated Mortality in an Urban Population With HIV and Lung Cancer: Implications for Patient Care

Richard D Moore, J. Herman, S. Baylin, 2006, Journal of acquired immune deficiency syndromes.

Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients

S. Klein, R. Ursin, A. Pekosz, 2021, medRxiv.

Avoidance, meaning and grief: psychosocial factors influencing engagement in HIV care

H. Hutton, R. Westergaard, J. Keruly, 2018, AIDS care.

Time Between Viral Loads for People With HIV During the COVID-19 Pandemic

Richard D Moore, K. Gebo, Y. Manabe, 2021, Journal of acquired immune deficiency syndromes.

Title: Time Between Viral Loads for People with HIV during the COVID-19 Pandemic

K. Gebo, G. Chander, J. Keruly, 2021 .

Effect of alcohol consumption on all‐cause and liver‐related mortality among HIV‐infected individuals

B. Lau, G. Chander, J. Keruly, 2017, HIV medicine.

Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.

Timothy R Sterling, Jeanne Keruly, Richard D Moore, 2003, The Journal of infectious diseases.

Absolute CD4 Vs. CD4 Percentage for Predicting the Risk of Opportunistic Illness in HIV Infection

Richard D Moore, J. Gallant, K. Gebo, 2004, Journal of acquired immune deficiency syndromes.

Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV

M. Budoff, S. Heckbert, M. Saag, 2023, HIV medicine.

The Impact of Youth-Friendly Structures of Care on Retention Among HIV-Infected Youth.

Richard D Moore, K. Gebo, J. Keruly, 2016, AIDS patient care and STDs.

Measuring Retention in HIV Care: The Elusive Gold Standard

G. Marks, A. Westfall, J. Davila, 2012, Journal of acquired immune deficiency syndromes.

Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy

Richard D Moore, K. Gebo, J. Keruly, 2003, Journal of general internal medicine.

Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics.

Richard D Moore, G. Marks, M. Mugavero, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune Status at Presentation for HIV Clinical Care in Rio de Janeiro and Baltimore

Richard D Moore, C. Struchiner, V. Veloso, 2011, Journal of Acquired Immune Deficiency Syndromes.

Comparison of Clinical Response to Initial Highly Active Antiretroviral Therapy in the Patients in Clinical Care in the United States and Brazil

Richard D Moore, V. Veloso, B. Grinsztejn, 2007, Journal of acquired immune deficiency syndromes.

Hepatitis C Elimination in People With HIV Is Contingent on Closing Gaps in the HIV Continuum

Richard D Moore, C. Sutcliffe, O. Falade-Nwulia, 2019, Open forum infectious diseases.

The Patient Reported Outcomes as a Clinical Tool (PROACT) Pilot Study: What Can be Gained by Sharing Computerized Patient-Reported Mental Health and Substance Use Symptoms with Providers in HIV Care?

Richard D Moore, B. Lau, M. Beach, 2021, AIDS and Behavior.

Riddhi A Modi, A. Westfall, M. Mugavero, 2020, AIDS care.

Acceptability of a mobile health intervention to enhance HIV care coordination for patients with substance use disorders

Pamela J. Surkan, Jeanne Keruly, Gregory D. Kirk, 2017, Addiction Science & Clinical Practice.

High hepatitis C cure rates among black and nonblack human immunodeficiency virus–infected adults in an urban center

C. Sutcliffe, O. Falade-Nwulia, G. Chander, 2017, Hepatology.

Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy.

Richard D Moore, R. Siliciano, J. Schiffer, 2020, The Journal of clinical investigation.

Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort

M. Budoff, S. Heckbert, M. Saag, 2022, HIV medicine.

Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers

Richard D Moore, J. Herman, M. Brock, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A qualitative study examining the benefits and challenges of incorporating patient-reported outcome substance use and mental health questionnaires into clinical practice to improve outcomes on the HIV care continuum

Richard D Moore, K. Riekert, G. Chander, 2018, BMC Health Services Research.

COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts

Richard D Moore, B. Lau, B. Mustanski, 2022, Drug and Alcohol Dependence.

Provider-Level and Other Health Systems Factors Influencing Engagement in HIV Care: A Qualitative Study of a Vulnerable Population

H. Hutton, R. Westergaard, J. Keruly, 2016, PloS one.

Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.

T Creagh-Kirk, R. Chaisson, D. Richman, 1992, AIDS.

Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group.

R. Chaisson, D. Richman, J. Keruly, 1991, Archives of internal medicine.

Clinic-wide Intervention Lowers Financial Risk and Improves Revenue to HIV Clinics Through Fewer Missed Primary Care Visits

G. Marks, L. Gardner, J. Raper, 2015, Journal of acquired immune deficiency syndromes.

Telemedicine Use Among People With HIV in 2021: The Hybrid-Care Environment

Richard D Moore, K. Gebo, G. Chander, 2022, Journal of acquired immune deficiency syndromes.

The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes.

A. Westfall, M. Mugavero, L. Gardner, 2015, American journal of public health.

Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic

Richard D Moore, B. Lau, K. Gebo, 2021, AIDS (London).

Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality.

Richard D Moore, S. Cole, A. Westfall, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

48. Time Between Viral Loads for Suppressed and Non-Suppressed People with HIV During the COVID-19 Pandemic Compared to Pre-Pandemic

B. Lau, K. Gebo, Y. Manabe, 2021, Open Forum Infectious Diseases.

Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda

Richard D Moore, R. Siliciano, T. Quinn, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Body shape and composition in HIV‐infected women: an urban cohort

J. Cofrancesco, J. Keruly, S. Barnett, 2005, HIV medicine.

Differences in HIV Disease Progression by Injecting Drug Use in HIV-Infected Persons in Care

Richard D Moore, R. Chaisson, J. Keruly, 2004, Journal of acquired immune deficiency syndromes.

Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection

Richard D Moore, R. Brookmeyer, O. Laeyendecker, 2013, PloS one.

The Effect of Buprenorphine on Human Immunodeficiency Virus Viral Suppression

Richard D Moore, B. Lau, G. Chander, 2021, Clinical Infectious Diseases.

Estimating the Cost of Increasing Retention in Care for HIV-Infected Patients: Results of the CDC/HRSA Retention in Care Trial

G. Marks, M. Mugavero, L. Gardner, 2015, Journal of acquired immune deficiency syndromes.

A low-effort, clinic-wide intervention improves attendance for HIV primary care.

Richard D Moore, G. Marks, M. Mugavero, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program

Richard D Moore, B. Lau, D. Fiellin, 2010, Annals of Internal Medicine.

Tobacco Smoking, Substance Use, and Mental Health Symptoms in People with HIV in an Urban HIV Clinic

Richard D Moore, B. Lau, H. Hutton, 2019, Journal of health care for the poor and underserved.

HIV Standard of Care for ART Adherence and Retention in Care Among HIV Medical Care Providers Across Four CNICS Clinics in the US

Riddhi A Modi, M. Mugavero, C. Golin, 2018, AIDS and Behavior.

Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients.

R. Chaisson, K. Gebo, J. Keruly, 1996, The Journal of infectious diseases.

Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients

S. Klein, R. Ursin, A. Pekosz, 2021, Open forum infectious diseases.

A Comparison of Methods for Analyzing Viral Load Data in Studies of HIV Patients

G. Marks, A. Westfall, J. Davila, 2015, PloS one.

Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.

Richard D Moore, J. Keruly, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Racial and Ethnic Differences in Outcome in Zidovudine-Treated Patients With Advanced HIV Disease

Douglas D. Richman, Harold A. Kessler, Richard D. Moore, 1991 .

Implementation of a COPD Screening Questionnaire in an Outpatient HIV Clinic

Richard D Moore, R. Wise, J. Keruly, 2016, COPD.

Ancillary service needs among persons new to HIV care and the relationship between needs and late presentation to care

B. Lau, M. Mugavero, G. Chander, 2019, AIDS care.

Alcohol Consumption and CD4 T-Cell Count Response Among Persons Initiating Antiretroviral Therapy

Richard D Moore, B. Lau, H. Hutton, 2012, Journal of acquired immune deficiency syndromes.

Mpox in people with advanced HIV infection: a global case series

B. Clotet, P. Cahn, J. Blanco, 2023, The Lancet.

Psychosocial and Service Use Correlates of Health-Related Quality of Life Among a Vulnerable Population Living with HIV/AIDS

A. Knowlton, J. Keruly, M. Mitchell, 2017, AIDS and Behavior.

Who Will Show? Predicting Missed Visits Among Patients in Routine HIV Primary Care in the United States

S. Boswell, M. Mugavero, E. Geng, 2018, AIDS and Behavior.

Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.

T Creagh-Kirk, R. Chaisson, D. Richman, 1991, JAMA.

Are missed- and kept-visit measures capturing different aspects of retention in HIV primary care?

A. Westfall, M. Mugavero, L. Gardner, 2020, AIDS care.

Clinic-Level Factors Associated with Retention in Care among People Living with HIV in a Multi-Site United States Cohort, 2010-2016.

Richard D Moore, M. Mugavero, P. Rebeiro, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load?

G. Marks, M. Mugavero, L. Gardner, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rapid Communication Hospital and Outpatient Health Services Utilization Among HIV‐Infected Patients in Care in 1999

Richard D Moore, J. Fleishman, R. Conviser, 2002, Journal of acquired immune deficiency syndromes.

Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts

Richard D Moore, H. Masur, C. Dieffenbach, 2021, Open forum infectious diseases.

The Effect Of Buprenorphine On HIV Viral Suppression.

Richard D Moore, B. Lau, A. Fojo, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association of medical insurance and other factors with receipt of antiretroviral therapy.

Richard D Moore, R. Conviser, J. Keruly, 2002, American journal of public health.

Assessing efficacy of a retention-in-care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use

G. Marks, L. Gardner, L. Metsch, 2016, AIDS.

Alcohol Use Disorder and Recent Alcohol Use and HIV Viral Non-Suppression Among People Engaged in HIV Care in an Urban Clinic, 2014–2018

Jessie K. Edwards, Richard D Moore, A. Fojo, 2021, AIDS and Behavior.

Abstract MP36: The Development Of A Centralized Recruitment Process For Covid-19 Research: Hopkins Opportunity For Participant Engagement Registry

Hailey N. Miller, J. Keruly, K. Gleason, 2021 .

Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US

M. Saag, K. Mayer, B. Whitney, 2021, medRxiv.

Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV.

J. Björkegren, P. Crane, S. Lindstrom, 2023, International journal of cardiology.

Chronic obstructive pulmonary disease and the risk for myocardial infarction by type in people with HIV

M. Budoff, S. Heckbert, M. Saag, 2022 .

The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts

Richard D Moore, B. Lau, B. Mustanski, 2022, Drug and Alcohol Dependence.

Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care Act.

Richard D Moore, J. Fleishman, L. Cheever, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors Associated with HIV Disclosure Status Among iENGAGE Cohort of New to HIV Care Patients.

Riddhi A Modi, A. Westfall, J. Willig, 2020, AIDS patient care and STDs.

Duration of the survival benefit of zidovudine therapy in HIV infection.

R. Chaisson, J. Keruly, R. Moore, 1996, Archives of internal medicine.

Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection.

R. Chaisson, J. Gallant, J. Keruly, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk

Richard D Moore, E. Fishman, S. Lai, 2013, Vascular health and risk management.

Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV clinic.

Richard D Moore, B. Lau, H. Hutton, 2017, Journal of substance abuse treatment.

Antiretroviral Therapy Use, Medication Adherence, and Viral Suppression Among PLWHA with Panic Symptoms

Richard D Moore, B. Lau, H. Hutton, 2015, Aids and Behavior.

Clinic-based Treatment for Opioid-dependent HIV-infected Patients versus Referral to an Opioid Treatment Program : A Randomized Controlled Trial

Woodson, Richard D Moore, B. Lau, 2010 .

Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020

Richard D Moore, M. Saag, Davey M. Smith, 2021, medRxiv : the preprint server for health sciences.

HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.

J. Clements, C. Merlo, R. Wise, 2016, The Journal of infectious diseases.